raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:247604

Juvenile primary lateral sclerosis

Synonyms: JPLS · Juvenile PLS

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood
Status
active

A very rare motor neuron disease characterized by progressive upper motor neuron dysfunction leading to loss of the ability to walk with wheelchair dependence, and subsequently, loss of motor speech production.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enJuvenile primary lateral sclerosisJPLS · Juvenile PLS
frSclérose latérale primitive juvénileJPLS · PLS juvénile · SLP juvénile
deLateralsklerose, juvenile primäre= en
esEsclerosis lateral primaria juvenilELP juvenil · JPLS · PLS juvenil
itSclerosi laterale primitiva giovanileJPLS · PLS giovanile
nlJuveniele primaire laterale scleroseJPLS · Juveniele PLS
ptEsclero lateral primária juvenil
plMłodzieńcze pierwotne stwardnienie boczneJplS · Młodzieńcze plS
csJuvenilní primární laterální sklerózaJPLS · Juvenilní PLS
ukЮвенільний первинний бічний склерозJPLS · Ювенільна PLS
zh少年型原发性侧索硬化症少年型PLS
trJuvenil primer lateral sklerozJPLS · jüvenil PLS

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM606353Evalidated
ICD-10G12.2NTBTattributedvalidated
MONDO0011663Evalidated
MeSHC536416Evalidated
UMLSC1853396Evalidated
GARD4485Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ERLIN2Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:1356ENSG000001474756116058p11.23ER lipid raft associated 223109145[PMID]
ALS2Disease-causing germline mutation(s) inAssessedHGNC:443ENSG000000033936063522q33.1alsin Rho guanine nucleotide exchange factor ALS219122027[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families4 casesWorldwideCase(s)ValidatedORPHANET
Point prevalence<1 / 1 000 000—EuropeClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

15 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0007256Abnormal pyramidal sign
HP:0002127Abnormal upper motor neuron morphology
HP:0002141Gait imbalance
HP:0001347Hyperreflexia
HP:0001324Muscle weakness
HP:0002193Pseudobulbar behavioral symptoms
HP:0002064Spastic gait
HP:0001285Spastic tetraparesis
HP:0001257Spasticity
Frequent (79-30%)
HP:0002015Dysphagia
HP:0002371Loss of speech
HP:0002464Spastic dysarthria
Occasional (29-5%)
HP:0000014Abnormality of the bladder
HP:0000763Sensory neuropathy
HP:0003202Skeletal muscle atrophy

Run the differential on the 9 obligate / very frequent terms

7

Sources for this card